CDEK
← All organizations
Urovant Sciences Ltd.

Urovant Sciences Ltd.

For profitWebsite ↗

Also known as: Lysovant | UROVANT | Urovant Sciences | Urovant Sciences GmbH | UROVANT SCIENCES GMBH

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Feb 28, 2018

First marketed drug

Dec 23, 2020

Last known activity

Aug 31, 2022

Acquired by Sumitomo Dainippon on Sep 6, 2019

Timeline

2010s

  1. Jan 1, 2016

    Urovant Sciences Ltd.— Founded

  2. Sep 6, 2019

    Sumitomo Dainippon— Acquired By

2020s

  1. Dec 23, 2020

    vibegron— Marketing Organization

Drugs by trial phase (4 distinct, 9 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (12)

Details

Founded
London, GB Jan 1, 2016
Last known activity
Aug 31, 2022